TRESIBA
TRESIBA
Approved
DIN Number
02467887
Drug Class
Human
Market Date
Sep 15, 2017
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02467887
AIG Number0159410002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE06 INSULIN DEGLUDEC
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN DEGLUDECActive
Strength: 200 UNIT / ML
Monograph: INSULIN DEGLUDEC